Viewing Study NCT05996601



Ignite Creation Date: 2024-05-06 @ 7:24 PM
Last Modification Date: 2024-10-26 @ 3:06 PM
Study NCT ID: NCT05996601
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-18
First Post: 2023-08-03

Brief Title: Evaluation of Improved Outcomes Among Ambulatory Diabetes andor Hypertensive Patients - an Intervention Study CPCLINT
Sponsor: University of Ibadan
Organization: University of Ibadan

Study Overview

Official Title: Evaluation of Selected Improved Outcomes Among Patients With Diabetes andor Hypertension in Designated Community Pharmacies in a Metropolitan City - An Intervention Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CPCLINT
Brief Summary: The goal of this interventional study is to compare improved outcomes among diabetes andor hypertensive patients sequel to educational intervention The study aims to answer the following questions

What are the patients levels of health literacy medication adherence disease knowledge attitude to disease physical activity
Does educational intervention by pharmacists improve health outcomes of patients with diabetes andor hypertension
Are there associations between patient-related variables such as health literacy medication adherence disease knowledge attitude to disease Participants anthropometric measurements and point-of-care testing for disease monitoring eg blood pressure blood glucose would be carried out Baseline assessment of participants would be done to evaluate their levels of health literacy medication adherence disease knowledge attitude to disease physical activity

Patients baseline assessment would be carried out after which they would receive educational materials and would be followed up by pharmacist The baseline assessments would be repeated at three and six months after the intervention to measure the effectiveness of the intervention
Detailed Description: The anthropometric measurements would include weight height waist circumference hip circumference from which the body mass index and waist-hip ration would be calculated

The assessment of the disease knowledge and attitude would be done using validated semi-structured questionnaires earlier designed by the principal investigator and used among ambulatory patients with diabetes andor hypertension accessing care in tertiary healthcare facilities The validated International Physical Activity Questionnaire IPAQ would be utilized for participants physical activity assessment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None